Surv BioPharma

Website
Current Valuation
$28.8M
As of November 11, 2025
Total Funding Raised
$17.2M
Last Round
Early Stage VC

$9.8M

Last Funding
Nov 2025

Funding date

Capital Efficiency
1.68x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Surv BioPharma is currently valued at $28.8M as of November 11, 2025. The company has raised a total of $17.2M in funding.

Capital Efficiency

With a capital efficiency ratio of 1.68x, Surv BioPharma has achieved a valuation that is 1.68 times the total capital raised.

Track Surv BioPharma Valuation Updates

Get notified when Surv BioPharma raises new funding or valuation changes

Explore More Data
Detailed analysis for Surv BioPharma

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Surv BioPharma's valuation history, funding rounds, and growth metrics.

No credit card required

What is Surv BioPharma Worth in 2026?

Surv BioPharma is a leading private company in the technology sector. Track Surv BioPharma's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Surv BioPharma Valuation is Determined

Private company valuations like Surv BioPharma's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.